Processa Pharmaceuticals, Inc.
PCSA
$1.99
-$0.17-7.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.99% | -19.15% | -23.10% | -1.53% | -30.68% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 50.00% | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 349.71% | -37.85% | -196.68% | 85.81% | 30.36% |
| Change in Net Operating Assets | -82.60% | -152.46% | 107.68% | 4.77% | 381.89% |
| Cash from Operations | 12.09% | -31.54% | -29.05% | 3.28% | 32.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -171.43% | 7.14% |
| Issuance of Common Stock | -95.01% | -94.48% | 442.25% | 207.09% | -- |
| Repurchase of Common Stock | 100.00% | 78.57% | 100.00% | 100.00% | -350.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.00% | -94.48% | 444.03% | 208.38% | 185,688.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -137.00% | -325.47% | 54.62% | 76.56% | 220.61% |